BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 26739636)

  • 1. Dynamic imbalance between cancer cell subpopulations induced by transforming growth factor beta (TGF-β) is associated with a DNA methylome switch.
    Martin M; Ancey PB; Cros MP; Durand G; Le Calvez-Kelm F; Hernandez-Vargas H; Herceg Z
    BMC Genomics; 2014 Jun; 15(1):435. PubMed ID: 24898317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy.
    Li J; Chen JN; Zeng TT; He F; Chen SP; Ma S; Bi J; Zhu XF; Guan XY
    BMC Cancer; 2016 Jan; 16():15. PubMed ID: 26758620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Aflatoxin M1 Effects on the Metabolomic and Cytokinomic Profiling of a Hepatoblastoma Cell Line.
    Marchese S; Sorice A; Ariano A; Florio S; Budillon A; Costantini S; Severino L
    Toxins (Basel); 2018 Oct; 10(11):. PubMed ID: 30373285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Environmental Pollutant Cadmium on the Establishment of a Cancer Stem Cell Population in Breast and Hepatic Cancer.
    Ju H; Arumugam P; Lee J; Song JM
    ACS Omega; 2017 Feb; 2(2):563-572. PubMed ID: 30023612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aflatoxin B1 and M1: Biological Properties and Their Involvement in Cancer Development.
    Marchese S; Polo A; Ariano A; Velotto S; Costantini S; Severino L
    Toxins (Basel); 2018 May; 10(6):. PubMed ID: 29794965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology and clinical implications of CD133(+) liver cancer stem cells.
    Ma S
    Exp Cell Res; 2013 Jan; 319(2):126-32. PubMed ID: 22999864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral overlap-free quantum dot-based determination of benzo[a]pyrene-induced cancer stem cells by concurrent monitoring of CD44, CD24 and aldehyde dehydrogenase 1.
    Shim Y; Song JM
    Chem Commun (Camb); 2015 Feb; 51(11):2118-21. PubMed ID: 25536409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
    Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
    Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
    Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
    Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.
    Lingala S; Cui YY; Chen X; Ruebner BH; Qian XF; Zern MA; Wu J
    Exp Mol Pathol; 2010 Aug; 89(1):27-35. PubMed ID: 20511115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk-eliminated quantitative determination of aflatoxin B1-induced hepatocellular cancer stem cells based on concurrent monitoring of CD133, CD44, and aldehyde dehydrogenase1.
    Ju H; Shim Y; Arumugam P; Song JM
    Toxicol Lett; 2016 Jan; 243():31-9. PubMed ID: 26739636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage checkpoint response to aflatoxin B1.
    Engin AB; Engin A
    Environ Toxicol Pharmacol; 2019 Jan; 65():90-96. PubMed ID: 30594067
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.